Massimo Pedrani
Director/Board Member chez Italian Pharmaceutical Association
Profil
Massimo Pedrani currently works at Italian Pharmaceutical Association, as Director from 1992 and Controlled Release Society Italy Local Chapter, as Director from 1998.
Mr. Pedrani also formerly worked at Cosmo Pharmaceuticals SA, as Head-Business Development Generics from 2001 to 2013 and Cosmo Pharmaceuticals NV, as Head-Generics Business Development.
Mr. Pedrani received his undergraduate degree from the University of Pavia.
Postes actifs de Massimo Pedrani
Sociétés | Poste | Début |
---|---|---|
Italian Pharmaceutical Association | Director/Board Member | 01/02/1992 |
Controlled Release Society Italy Local Chapter | Director/Board Member | 01/06/1998 |
Anciens postes connus de Massimo Pedrani
Sociétés | Poste | Fin |
---|---|---|
COSMO PHARMACEUTICALS N.V. | Corporate Officer/Principal | - |
Cosmo Pharmaceuticals SA
Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cosmo Pharmaceuticals SA operates as a pharmaceutical company that engages in the manufacturing of pharmaceutical drugs. It focuses on the development of gastro-intestinal pharmaceutical products for the treatment of inflammatory bowel diseases, colon infections and colon diagnosis, and treated skin disorders. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Lainate, Italy. | Corporate Officer/Principal | - |
Formation de Massimo Pedrani
University of Pavia | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 1 |
---|---|
COSMO PHARMACEUTICALS N.V. | Health Technology |
Entreprise privées | 3 |
---|---|
Cosmo Pharmaceuticals SA
Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cosmo Pharmaceuticals SA operates as a pharmaceutical company that engages in the manufacturing of pharmaceutical drugs. It focuses on the development of gastro-intestinal pharmaceutical products for the treatment of inflammatory bowel diseases, colon infections and colon diagnosis, and treated skin disorders. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Lainate, Italy. | Health Technology |
Italian Pharmaceutical Association | |
Controlled Release Society Italy Local Chapter |